僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Priliximab （CEN 000029） is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can be used in research of rheumatoid arthritis （RA）